Noah G. Levy - Net Worth and Insider Trading

Noah G. Levy Net Worth

The estimated net worth of Noah G. Levy is at least $17 Million dollars as of 2024-05-29. Noah G. Levy is the of Merrimack Pharmaceuticals Inc and owns about 1,119,586 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $17 Million. Details can be seen in Noah G. Levy's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Noah G. Levy has not made any transactions after 2023-01-12 and currently still holds the listed stock(s).

Transaction Summary of Noah G. Levy

To

Noah G. Levy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Noah G. Levy owns 4 companies in total, including Merrimack Pharmaceuticals Inc (MACK) , Garrett Motion Inc (GTXMQ) , and Garrett Motion Inc (GTX) among others .

Click here to see the complete history of Noah G. Levy’s form 4 insider trades.

Insider Ownership Summary of Noah G. Levy

Ticker Comapny Transaction Date Type of Owner
MACK Merrimack Pharmaceuticals Inc 2023-01-12 director & other: See Remarks
GTXMQ Garrett Motion Inc 2020-10-20 other: Member of 10% owner group
GTX Garrett Motion Inc 2020-10-20 other: Member of 10% owner group
2021-10-12 director

Noah G. Levy Latest Holdings Summary

Noah G. Levy currently owns a total of 1 stock. Noah G. Levy owns 1,119,586 shares of Merrimack Pharmaceuticals Inc (MACK) as of January 12, 2023, with a value of $17 Million.

Latest Holdings of Noah G. Levy

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MACK Merrimack Pharmaceuticals Inc 2023-01-12 1,119,586 15.13 16,939,336

Holding Weightings of Noah G. Levy


Noah G. Levy Form 4 Trading Tracker

According to the SEC Form 4 filings, Noah G. Levy has made a total of 22 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years, including 22 buys and 0 sells. The most-recent trade in Merrimack Pharmaceuticals Inc is the acquisition of 100,000 shares on January 12, 2023, which cost Noah G. Levy around $1 Million.

Insider Trading History of Noah G. Levy

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Noah G. Levy Trading Performance

GuruFocus tracks the stock performance after each of Noah G. Levy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Noah G. Levy is 9.77%. GuruFocus also compares Noah G. Levy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Noah G. Levy within 3 months outperforms 9 times out of 21 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Noah G. Levy's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Noah G. Levy

Average Return

Average return per transaction

Outperforming Transactions

21 out of 22 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 16.96
Relative Return to S&P 500(%) 13.67

Noah G. Levy Ownership Network

Ownership Network List of Noah G. Levy

No Data

Ownership Network Relation of Noah G. Levy


Noah G. Levy Owned Company Details

What does Merrimack Pharmaceuticals Inc do?

Who are the key executives at Merrimack Pharmaceuticals Inc?

Noah G. Levy is the director & other: See Remarks of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and other: See Remarks Newtyn Management, Llc .

Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary

Over the past 18 months, Noah G. Levy made 1 insider transaction in Merrimack Pharmaceuticals Inc (MACK) with a net purchase of 100,000. Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 942,726 shares made by Eric Andersen , a net purchase of 4,156 shares made by Ana Radeljevic , and a net purchase of 4,000 shares made by Gary L Crocker .

In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 1,050,882 shares were bought by its insiders, resulting in a net purchase of 1,050,882 shares.

Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Merrimack Pharmaceuticals Inc Insider Transactions

No Available Data

Noah G. Levy Mailing Address

Above is the net worth, insider trading, and ownership report for Noah G. Levy. You might contact Noah G. Levy via mailing address: 60 East 42nd St, 9th Floor, New York Ny 10165.

Discussions on Noah G. Levy

No discussions yet.